The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Goode, expressed enthusiasm about the results, indicating that this technology brings continuous glucose monitoring ... with diabetes. Glucotrack’s CBGM is a long-term, implantable system ...

Glucotrack's CGM is designed as a long-term implantable device, intended for three years of continuous use without the need for an on-body external component, aiming to offer a less intrusive and ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack ... marking a significant milestone in continuous glucose monitoring. This study represents the first real-time, continuous blood ...